Evidence map›Paper›PMID 11290540›Full record

ArticleThe American journal of pathology2001

Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray.

S Li, D T Ross, M E Kadin, P O Brown, M A Wasik

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The American journal of pathology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. An Activated GOPS-poly-Engineering in life sciences · 2005
    Article
  9. Article
  10. Article
  11. Microarray analysis of B-cell lymphoma cell lines with the t(14;18).The Journal of molecular diagnostics : JMD · 2002
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

S LiDepartment of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Founders 7.06, 3400 Spruce Street, Philadelphia, PA 19104, USA.
D T Ross
M E Kadin
P O Brown
M A Wasik
Howard Hughes Medical Institute · USBeth Israel Deaconess Medical Center · USStanford University · USUniversity of Pennsylvania · US

Funding

Jak/STAT signaling in human T-cell lymphomasR01CA089194 · NCI · UNIVERSITY OF PENNSYLVANIA · PI WASIK, MARIUSZ A. · 2001 to 2010
$2.5M
APPLYING GENOMIC MISMATCH SCANNING TO THE GENOMER01HG000450 · NHGRI · STANFORD UNIVERSITY · PI BROWN, PATRICK O. · 1994 to 1999
–
EFFICIENT GENE MAPPING BY WHOLE GENOME MISMATCH SCANNINGR21HG000450 · NHGRI · STANFORD UNIVERSITY · PI BROWN, PATRICK O. · 1991 to 1993
–
NCI NIH HHS CA89194NCI NIH HHS R01 CA089194NHGRI NIH HHS HG00450
6 · The paper itself

Abstract

Using a cDNA microarray, we compared the expression of approximately 8000 genes between two unique, clonally related T cell lines derived from different stages of a progressive T cell lymphoma involving skin. A total of 180 genes was found to be differentially expressed at the RNA level by a factor of fivefold or greater. Compared with the cells from the earlier, clinically indolent stage of the lymphoma, 56 genes were up-regulated, whereas 124 genes were down-regulated in the cells from the advanced, clinically aggressive stage lymphoma. The functions of approximately 65% of these genes are currently unknown. The 22 genes with a known function that were up-regulated in the advanced lymphoma cells included several genes involved in promotion of cell proliferation and survival as well as drug resistance. The 42 functionally characterized genes that were down-regulated in the advanced lymphoma cells included negative regulators of cell activation and cell cycle, and mediators of cell adhesion, apoptosis, and genome integrity. The differential expression identified by the cDNA microarray analysis was confirmed for selected genes by reverse transcription-polymerase chain reaction and Northern blotting. The identified differences in gene expression may be related to the differences in behavior between the early and advanced stages of the T cell lymphoma and point to directions for further investigations into mechanisms of lymphoma progression.

Indexed as

Gene Expression ProfilingOligonucleotide Array Sequence AnalysisBlotting, NorthernDisease ProgressionDNA, ComplementaryHumansLymphoma, T-CellReverse Transcriptase Polymerase Chain ReactionTumor Cells, CulturedDNA, Complementary

Identifiers

PMID11290540
PMCPMC1891906
OpenAlexW2064549663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.